… treatment of lower-genital tract dysplasia using … vaccine. We calculated relative risk ratios
for all outcomes over the 5-year period for the unvaccinated group compared to the vaccinated …

… vaccine. Uptake rates were approximately 60%. We followed these women from age 18–23
years (5 years) and identified low… and treatment of lower-genital tract dysplasia using Ontario …

… qHPV vaccine and Ontario’s grade 8 qHPV vaccination program on cervical dysplasia and
… Importantly, our findings revealed that despite relatively low qHPV vaccine coverage in …

… between lower genital tract and anal dysplasia and cancer, … cervical cancer screening
programs in reducing the burden of … ) status; and previous HPV vaccination. Pathology reports and …

… lower genital tract dysplasia and malignancy. We also found high rates of anal dysplasia
in both groups with a trend towards increased rate in those women with history of genital …

… the HPV vaccination in their national immunization program as of … for the treatment of cervical
dysplasia. For women younger than … Although HPV vaccination is a well-recognized and …

… dysplastic lesions in the female lower genital tract, we identified 21 patients who had high-grade
vaginal … Among these 21 patients, 11 had vaginal or vulvar lesions that were positive for …

… and who developed lower genital tract dysplasia) would not benefit from vaccination, we …
We collected data from patients with a diagnosis of lower genital tract dysplasia (LGTD) …

… lower population levels of genital warts and cervical dysplasia in the years after vaccination.
… a 2-dose schedule, Gavi, the Vaccine Alliance countries are required to use a 2-dose …

… HPV vaccines promise to dramatically reduce the incidence of HPV infection, genital warts,
… , but most infections and low-grade dysplasia are cleared spontaneously by the immune …